Sinovac Biotech Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sinovac Biotech Ltd's inventory turnover ratio, the ratio that measures Sinovac Biotech Ltd's ability to manage its supply chain, sequentially decreased to 1.31 in the fourth quarter 2025, which does not come as a surprise, as the Sinovac Biotech Ltd continue to experience headwinds, which also impact its supply chain. Sinovac Biotech Ltd's average inventory processing period in the Dec 31 2025 quarter, has increased to 279 days, from 203 days, in the 0 quarter.

Within Healthcare sector 294 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the third quarter 2025, to 1871.

SVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sinovac Biotech Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SVA Inventory Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Inventory Growth	233.52 %	-2.69 %	-2.69 %	-2.69 %	-18.25 %
Y / Y Cost of Sales Growth	-11.43 %	-	-	-	-22.65 %
Inventory Turnover Ratio (TTM)	1.31	-	-	-	1.76
SVA's Total Ranking	# 1871	# 0	#	#	#
Average inventory processing period	278	-	-	-	208
Seq. Inventory Growth	0 %	0 %	0 %	233.52 %	-70.82 %
Seq. Cost of Sales Growth	-	-	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 79
Healthcare Sector	# 295
Overall Market	# 1871

Inventory Turnover Ratio Statistics
High	Average	Low
4.65	1.8	0.79
(Dec 31 2022)		(Dec 31 2020)

SVA Company Profile >> Back to SVA Efficiency Comparisons >> Compare SVA Inventory Turnover Ratio to its Competitors

Financial Statements
Sinovac Biotech Ltd's Inventories	$ 94 Millions	Visit SVA's Balance sheet
Sinovac Biotech Ltd's Cost of Revenues TTM	$ 124 Millions	Visit SVA's Income Statement
What are SVA's Sales?		Visit SVA's Sales by Segment

Other Inventory Turnover Ratios
Sinovac Biotech Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SVA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SVA's Competitors
Inventory Turnover Ratio for SVA's Suppliers
Inventory Turnover Ratio for SVA's Customers

You may also want to know
SVA's Sales Growth Rates	SVA's Pe Price to earnings ratio	SVA's Receivables Turnover Ratio	SVA's Stock Quote
SVA's Net Income Growth Rates	SVA's Ps Price to Sales ratio	SVA's Sales per Employee	SVA's Asset Turnover Ratio
SVA's Net Margin	SVA's Pb Price to Book ratio	SVA's Financial Strength Ratios	SVA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Dec 31 2025	Inventories at quarter ending Dec 31 2025
Alpha Teknova Inc	3.59	$ 25.248 Millions	$ 7 Millions
Inmed Pharmaceuticals Inc	3.51	$ 3.169 Millions	$ 1 Millions
Gilead Sciences Inc	3.49	$ 6,234.000 Millions	$ 1,786 Millions
Cannapharmarx Inc	3.47	$ 3.447 Millions	$ 1 Millions
Solventum Corporation	3.45	$ 3,402.000 Millions	$ 986 Millions
Exelixis Inc	3.44	$ 83.697 Millions	$ 24 Millions
Tandem Diabetes Care Inc	3.40	$ 467.746 Millions	$ 137 Millions
Baxter International Inc	3.40	$ 7,865.000 Millions	$ 2,312 Millions
Burning Rock Biotech Limited	3.39	$ 19.542 Millions	$ 6 Millions
Biocryst Pharmaceuticals Inc	3.38	$ 19.075 Millions	$ 6 Millions
Cadre Holdings inc	3.38	$ 350.000 Millions	$ 103 Millions
Mirum Pharmaceuticals Inc	3.37	$ 79.434 Millions	$ 24 Millions
Insight Molecular Diagnostics Inc	3.37	$ 1.743 Millions	$ 1 Millions
Catalyst Pharmaceuticals Inc	3.37	$ 87.253 Millions	$ 26 Millions
Agilent Technologies inc	3.33	$ 3,375.000 Millions	$ 1,014 Millions
Maravai Lifesciences Holdings Inc	3.31	$ 151.000 Millions	$ 46 Millions
Sonoma Pharmaceuticals Inc	3.30	$ 10.960 Millions	$ 3 Millions
Zai Lab Limited	3.28	$ 128.249 Millions	$ 39 Millions
Dexcom Inc	3.18	$ 1,860.000 Millions	$ 586 Millions
Iovance Biotherapeutics inc	3.17	$ 173.184 Millions	$ 55 Millions
Nuvation Bio Inc	3.17	$ 14.000 Millions	$ 4 Millions
Amneal Pharmaceuticals Inc	3.13	$ 1,905.000 Millions	$ 608 Millions
Prestige Consumer Healthcare Inc	3.11	$ 484.000 Millions	$ 156 Millions
Nexgel Inc	3.08	$ 6.000 Millions	$ 2 Millions
Mettler toledo International Inc	3.05	$ 1,170.864 Millions	$ 384 Millions
Urogen Pharma Ltd	3.05	$ 12.447 Millions	$ 4 Millions
10x Genomics Inc	3.02	$ 198.000 Millions	$ 65 Millions
Becton Dickinson And Company	3.02	$ 11,823.000 Millions	$ 3,913 Millions
Bausch Health Companies Inc	3.01	$ 2,949.000 Millions	$ 979 Millions
Intelligent Bio Solutions Inc	2.98	$ 1.926 Millions	$ 1 Millions

Date modified: 2026-07-07T13:28:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.